Product Development

CMC Outsourcing Support

Helping you navigate complex discovery, selection, and management needs

Our subject matter experts guide you in all phases of finding, engaging, and managing a CDMO. We create tailored evaluation criteria designed around your day-to-day needs as well as your short- and long-term business goals. Our services will:
  • Identify, evaluate, and select CDMOs based on fit for project and client
  • Review and help negotiate master services agreements
  • Manage CDMOs and advocate on behalf of client to achieve desired outcome and deliverables

We also support and oversee the following processes:

  • Cell line, process, and formulation development
  • Development and validation of analytical methods for in-process, release, and stability
  • Design specifications for release of bulk drug substance and products
  • Clinical filling of drug products
  • Clinical packaging, labeling, and distribution
  • Process validation
  • Commercial manufacturing

Why choose Alira Health?

As our client, you can rely on Alira Health’s dedicated, knowledgeable team to lead and support your outsourcing activities. You’ll benefit from our:

  • Extensive industry outsourcing expertise in the identification, evaluation, and selection of CDMOs, and managing the relationship with CDMOs to ensure that the client’s needs are met
  • Strong technical management at all stages from preclinical process development through manufacturing
  • Commitment to client advocacy with vendors that drives holistic solutions tailored to your business needs and goals
  • Full spectrum development support from product decision through clinical trials, process validation, and commercial manufacturing
  • Packaging, labeling, and shipping support and management

Related news

Advanced Analytics Digital Health Pharma Research & Development
Publications December 10, 2021
Leveraging Data Intelligence for Effective Opportunity Screening and Prioritization in Drug Discovery
Our biotech client needed an innovative, effective way to identify which binding sites and therapeutic indications they should target for the development of new therapeutic agents for(...)
Research & Development
Events November 24, 2021
Event: Innovations In Wound Healing Annual Conference
Join Dr. Mitch Sanders for an exclusive poster session at this event.
Research & Development
Events October 20, 2021
Event: SAWC Fall 2021
Join Dr. Sanders at SAWC Fall in Las Vegas, NV.
Due Diligence Research & Development
Publications August 18, 2021
Infographic: Indication Prioritization and Pre-Commercial Value Assessment
Download our infographic on Indication Prioritization and Pre-Commercial Value Assessment.
Pharma Research & Development
Publications August 2, 2021
Infographic: Prioritization Strategy of R&D Targets for Biotech Company
Download our infographic on Prioritization Strategy of R&D Targets for Biotech Company
Research & Development
Publications June 9, 2021
EU Supply Integrity Guidelines
Check out Alira Health's latest publication, “EU Supply Integrity Guidelines”. In the document, best practices for European distribution and supply integrity management are highlighted(...)
Research & Development
Publications May 27, 2021
Buffers – Navigating New Demands On Downstream Raw Materials
The COVID-19 pandemic has put unusual pressures on the supply and demand of raw materials required for the production and purification of biologics. A specific concern for the biomanufacturing(...)
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.